Hungary: Life Sciences, Biotechnology & Nanotechnology

Hungarian hospitals are facing problems paying for drugs and medical devices. Many suppliers have claims worth millions of euros and are having difficulty enforcing them against either the hospitals or the Hungarian government.

The first plenary session of the EU Parliament in the second semester of 2018 was held on 11 September, where the main challenges and topics of the next six month have been outlined.

This article tries to shed light on an important area of trade mark law in connection with a decision recently handed down by the European Court of First Instance (the "CFI"), more specifically with respect to the complex question of similarity between marks and confusion of the public.